Atacand candesartan cilexetil: Began Phase III study

AstraZeneca plc (AZN), London, U.K. Product: Atacand candesartan cilexetil Business: Ophthalmic Therapeutic category: Receptor antagonist Target: Angiotensin II receptor Description: Small molecule a...